CIC
PBYI icon

Cornercap Investment Counsel’s Puma Biotechnology PBYI Stock Holding History

Cornercap Investment Counsel’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-126,963
Closed -$448K – 638
2023
Q2 		$448K Buy
126,963
+2,044
+2% +$6.38K 0.08% 431
2023
Q1 		$386K Buy
+124,919
New +$471K 0.07% 449

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cornercap Investment Counsel's PBYI Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of Puma Biotechnology (PBYI) in Q3 2023, closing a stake of 126,963 shares — an estimated $448K sold.

Cornercap Investment Counsel first reported a position in PBYI in Q1 2023 and held it in 2 quarters. The position peaked at $448K in Q2 2023. 69 funds tracked by Wall St. Rank hold PBYI as of Q3 2023.

  • Cornercap Investment Counsel reported no remaining Puma Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 126,963 Puma Biotechnology shares in Q3 2023, an estimated $448K.
  • Cornercap Investment Counsel first reported a position in Puma Biotechnology in Q1 2023 and held it in 2 quarters.
  • Cornercap Investment Counsel's Puma Biotechnology position peaked at $448K in Q2 2023.
  • 69 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.